Puma Biotechnology (PBYI) Asset Utilization Ratio (2018 - 2026)
Puma Biotechnology (PBYI) posted Asset Utilization Ratio of 1.11 for Q1 2026, up 1.95% on a QoQ basis from 1.09 in Q4 2025, and down 2.25% year-over-year from 1.14 in Q1 2025.
Puma Biotechnology (PBYI) Asset Utilization Ratio (2018 - 2026) Analysis & Trends
Puma Biotechnology's Asset Utilization Ratio history runs 9 years deep, the most recent figure standing at 1.11 for Q1 2026.
- Quarterly Asset Utilization Ratio fell 2.25% year-over-year to 1.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.11 (down 2.25% YoY) and the FY2025 annual result came in at 1.06, up 2.37% from the prior year.
- Asset Utilization Ratio was 1.11 for Q1 2026 at Puma Biotechnology, up from 1.09 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.27 in Q2 2023 and bottomed at 0.94 in Q1 2022.
- A 5-year average of 1.12 and a median of 1.11 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 30.8% — and 2024, when it slipped 17.71%.
- Puma Biotechnology's Asset Utilization Ratio stood at 1.19 in 2022, then fell by 8.63% to 1.09 in 2023, then declined by 2.18% to 1.06 in 2024, then rose by 2.61% to 1.09 in 2025, then increased by 1.95% to 1.11 in 2026.
- Business Quant data shows PBYI's Asset Utilization Ratio at 1.11 in Q1 2026, 1.09 in Q4 2025, and 1.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | 1.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.11 |
| Dec 31, 2025 | 1.09 |
| Sep 30, 2025 | 1.07 |
| Jun 30, 2025 | 1.22 |
| Mar 31, 2025 | 1.14 |
| Dec 31, 2024 | 1.06 |
| Sep 30, 2024 | 1.14 |
| Jun 30, 2024 | 1.05 |
| Mar 31, 2024 | 1.02 |
| Dec 31, 2023 | 1.09 |
| Sep 30, 2023 | 1.24 |
| Jun 30, 2023 | 1.27 |
| Mar 31, 2023 | 1.23 |
| Dec 31, 2022 | 1.19 |
| Sep 30, 2022 | 1.11 |
| Jun 30, 2022 | 1.05 |
| Mar 31, 2022 | 0.94 |
| Dec 31, 2021 | 1.12 |
| Sep 30, 2021 | 1.03 |
| Jun 30, 2021 | 0.98 |